We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Kinovate Life Sciences Launches Carrigene® Plates for in Vitro Transfection of Plasmid DNA
Product News

Kinovate Life Sciences Launches Carrigene® Plates for in Vitro Transfection of Plasmid DNA

Kinovate Life Sciences Launches Carrigene® Plates for in Vitro Transfection of Plasmid DNA
Product News

Kinovate Life Sciences Launches Carrigene® Plates for in Vitro Transfection of Plasmid DNA


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Kinovate Life Sciences Launches Carrigene® Plates for in Vitro Transfection of Plasmid DNA "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Kinovate Life Sciences, Inc has announced that it will officially launch CarriGene® Plates - a fast transfection plate product for in vitro delivery of plasmid DNA to mammalian cells.

CarriGene® Plates will be available in 6, 12, 24-well and 10 cm dish formats for routine transfection and viral vector production, as well as the 96-well format for high throughput screening applications.

The Plates are pre-coated with Kinovate’s biodegradable cationic polymer transfection reagent, which delivers high transfection efficiency across a broad range of mammalian cell lines with low toxicity.

This patented technology offers a DNA transfection reagent pre-coated onto plates. Using this format, researchers are able to simplify and speed up the transfection process.

The Company says that the CarriGene® Plates have been rigorously tested across a broad range of cell lines and transfection efficiency with superior cell viability in comparison with conventional reagent products on the market.

Advertisement